FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
On Thursday the FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 9-1 in favor of approval for Daiichi Sankyo’s edoxaban(Savaysa), but the outcome will likely result in a drug that will be...
View ArticleFDA Approves New Oral Anticoagulant From Daiichi Sankyo
And then there were four. Late Thursday the FDA announced that it had approved edoxaban, the new oral anticoagulant manufactured by Daiichi Sankyo. The drug will be marketed under the brand name of...
View Article
More Pages to Explore .....